CGEN
Compugen Ltd. Healthcare Biotechnology
8/12
Innovation Score
Patent Activity
0/3
No patents found in USPTO database (last 2026-05-11 02:16).
Cash Runway
3/3
Operating cash flow positive — self-funding.
Cash on hand: $145.6M
Cash on hand: $145.6M
Revenue Trajectory
3/3
Revenue: $72.8M
YoY Growth: +4477.3%
YoY Growth: +4477.3%
Management Quality
2/3
Insider ownership: 2.3%
SBC/Revenue: 0.0%
No reverse splits detected
SBC/Revenue: 0.0%
No reverse splits detected
Key Metrics
Market Cap
$274.2M
Revenue
$72.8M
Revenue Growth (YoY)
+4477.3%
Cash on Hand
$145.6M
Cash Runway
Cash Flow Positive
Shares Outstanding
94.6M
Insider Ownership
2.3%
SBC / Revenue
0.0%
Sector / Industry
Healthcare / Biotechnology
7-Step Risk Assessment
How CGEN maps to our micro cap methodology:
- Innovation Signal No patents found. Innovation may be trade-secret-based or too early for filings.
- Cash Runway Check Cash flow positive. No dilution risk from capital raises.
- Revenue Trajectory +4477.3% YoY growth on $72.8M revenue. Strong growth trajectory.
- Management Alignment Insiders hold 2.3% of shares. SBC is 0.0% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $274.2M company.
Financial Detail
Free Cash Flow
$24.3M
FCF Yield
8.9%
Return on Equity
44.8%
Debt / Equity
2.9%
Gross Margin
87.3%
Profit Margin
48.6%
Operating Margin
83.2%
Price / Book
2.67
Current Ratio
6.56
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Quality Flags
Buffett Quality
Wide Moat
High ROE
Low Debt
FCF Positive
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-05-11